Results from the children's study will be presented June 10th in San Diego

On Saturday, June 10, Erik Ising, PhD student at the Department of Clinical Sciences Malmö - Pediatric Endocrinology will presents his findings from a study using VibroSense instruments for detection of early signs of neuropathy in childhood and adolescents type 1 diabetes.

The results are presented at a poster session included in the category "Complications-Neuropathy" at the American Diabetes Association's 77th Scientific Sessions in San Diego, California, June 9-13.

Toni Speidel, CEO VibroSense Dynamics AB,
Tel: +46 40 650 14 12
E-mail: info@vibrosense.com
www.vibrosense.com


VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in the legs and arms. The Company, founded in 2005, has been listed on AktieTorget since May 2015.

About Us

VibroSense Dynamics AB (public) sells and develops efficient systems to support early detection and diagnosis of sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in e.g. legs and arms. The Company, founded in 2005, has been listed on Spotlight stock market since May 2015. Our vision is that the VibroSense Meter shall be the golden standard instrument for neurological examinations to assess sensory neuropathy and help to improve life conditions for patients having a risk of getting nerve injuries.

Subscribe

Documents & Links